Literature DB >> 24172796

Toward immunosuppressive effects on liver transplantation in rat model: tacrolimus loaded poly(ethylene glycol)-poly(D,L-lactide) nanoparticle with longer survival time.

Wei Xu1, Peixue Ling2, Tianmin Zhang3.   

Abstract

In this study, tacrolimus (FK506) was encapsulated into a biodegradable poly(ethylene glycol)-poly(D,L-lactide) (MPEG-PLA) block copolymer using a double emulsion-solvent evaporation technique. Drug loading (DL) and encapsulation efficiency (EE) can be changed by varying the mass ratio of FK506/MPEG-PLA. Furthermore, transmission electron microscope (TEM) and Malvern Zetasizer were used to investigate the properties of FK506/MPEG-PLA nanoparticles (DL=9.5%), which were monodisperse (PDI=0.100 ± 0.023) with a mean particle size of 90.5 ± 1.5 nm. Compared with FK506 capsule, in vitro release profile showed that FK506/MPEG-PLA nanoparticles exhibited sustained release. Meanwhile, the higher concentration and longer retention time in plasma were also confirmed in vivo. We further preliminarily evaluated immunosuppressive effect on liver transplantation in rat model. The survival time of the rat administrated FK506/MPEG-PLA nanoparticles was obviously prolonged than that of the control group administrated FK506 capsule.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Immunosuppressive; Liver transplantation; MPEG-PLA; Nanoparticle; Tacrolimus

Mesh:

Substances:

Year:  2013        PMID: 24172796     DOI: 10.1016/j.ijpharm.2013.10.035

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  12 in total

Review 1.  Active targeted delivery of immune therapeutics to lymph nodes.

Authors:  Baharak Bahmani; Ishaan Vohra; Nazila Kamaly; Reza Abdi
Journal:  Curr Opin Organ Transplant       Date:  2018-02       Impact factor: 2.640

Review 2.  Nanoparticles and direct immunosuppression.

Authors:  Terrika A Ngobili; Michael A Daniele
Journal:  Exp Biol Med (Maywood)       Date:  2016-05

Review 3.  Tolerogenic dendritic cells in organ transplantation.

Authors:  Jordi Ochando; Farideh Ordikhani; Stefan Jordan; Peter Boros; Angus W Thomson
Journal:  Transpl Int       Date:  2019-10-29       Impact factor: 3.782

Review 4.  Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.

Authors:  Kelan A Hlavaty; Xunrong Luo; Lonnie D Shea; Stephen D Miller
Journal:  Clin Immunol       Date:  2015-03-21       Impact factor: 3.969

5.  Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension.

Authors:  Zimeng Wang; Julie L Cuddigan; Sweta K Gupta; Samantha A Meenach
Journal:  Int J Pharm       Date:  2016-08-26       Impact factor: 5.875

6.  Nanotechnological Approaches to Immunosuppression and Tolerance Induction.

Authors:  Kunal Patel; Carl Atkinson; Danh Tran; Satish N Nadig
Journal:  Curr Transplant Rep       Date:  2017-04-17

7.  Biodegradable micelles enhance the antiglioma activity of curcumin in vitro and in vivo.

Authors:  Songping Zheng; Xiang Gao; Xiaoxiao Liu; Ting Yu; Tianying Zheng; Yi Wang; Chao You
Journal:  Int J Nanomedicine       Date:  2016-06-09

8.  Sustained Release of Immunosuppressant by Nanoparticle-anchoring Hydrogel Scaffold Improved the Survival of Transplanted Stem Cells and Tissue Regeneration.

Authors:  Ruixiang Li; Jianming Liang; Yuwei He; Jing Qin; Huining He; Seungjin Lee; Zhiqing Pang; Jianxin Wang
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

Review 9.  Tolerizing Strategies for the Treatment of Autoimmune Diseases: From ex vivo to in vivo Strategies.

Authors:  Anje Cauwels; Jan Tavernier
Journal:  Front Immunol       Date:  2020-05-14       Impact factor: 7.561

10.  A Mixed Thermosensitive Hydrogel System for Sustained Delivery of Tacrolimus for Immunosuppressive Therapy.

Authors:  Hsiu-Chao Lin; Madonna Rica Anggelia; Chih-Chi Cheng; Kuan-Lin Ku; Hui-Yun Cheng; Chih-Jen Wen; Aline Yen Ling Wang; Cheng-Hung Lin; I-Ming Chu
Journal:  Pharmaceutics       Date:  2019-08-14       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.